AREV I has acquired a stake in Ysonut, a leader in micronutrition and dietary supplements, aiming to enhance growth and expand market presence in France and Spain.
Target Company Information
Ysonut is an international laboratory specializing in active nutrition science, dedicated to the holistic health of its patients. As a pioneer in micronutrition and dietary solutions for over 30 years, Ysonut offers two prominent brands: Inovance, which focuses on micronutrition and dietary supplements, and Protéifine, centered on protein diets. Both brands are distinguished by the efficacy of their superior quality formulations.
Founded in Montpellier by Marc Sarazin, Ysonut has been based in Barcelona since 1998. The company has historically expanded its presence in France and Spain, and since the early 2000s, has begun its internationalization journey, reaching markets in Europe (Belgium and Portugal) and extending its reach to Latin America (Argentina, Uruguay, and Mexico).
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The nutrition and dietary supplement industry in both France and Spain is experiencing significant growth, driven by increasing consumer awareness regarding health and wellness. Th
Similar Deals
Fonds Patient Autonome, Bpifrance, UNIQA, UI Investissement → Fizimed
2025
AREV I
invested in
Ysonut
in 2024
in a Other VC deal